Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group (Q33374055)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group |
scientific article |
Statements
1 reference
Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group (English)
1 reference
Birgit Geoerger
1 reference
Anne Geoffray
1 reference
Susan Picton
1 reference
Bruce Morland
1 reference
Gilles Vassal
1 reference
Dominique Couanet
1 reference
Elizabeth Stockdale
1 reference
Daniel Orbach
1 reference
Fabienne Pichon
1 reference
Jean Claude Gentet
1 reference
Christophe Bergeron
1 reference
Laura Cisar
1 reference
Sylvie Assadourian
1 reference
French Society of Pediatric Oncology
1 reference
United Kingdom Children's Cancer Study Group
1 reference
1 February 2007
1 reference
1 reference
25
1 reference
356-361
1 reference
Identifiers
1 reference
1 reference